Case StudiesNov 08, 2024
Co-processing: How Porton J-STAR is Supporting Pharma's Adoption of New Enabling Technologies
What is co-processing and how is the industry embracing it?
Case StudiesNov 08, 2024
Co-processing: How Porton J-STAR is Supporting Pharma's Adoption of New Enabling Technologies
ASD - How Co-Processing can replace Spray Drying
Case StudiesNov 08, 2024
Co-processing: How Porton J-STAR is Supporting Pharma's Adoption of New Enabling Technologies
Adsorption
Case StudiesNov 08, 2024
Co-processing: How Porton J-STAR is Supporting Pharma's Adoption of New Enabling Technologies
Heterogeneous nucleation (HN)
Small MoleculesOct 29, 2024
ENT-03 GRC Poster
ENT-03 was predicted to be the mammalian equivalent of trodusquemine, based on knowledge of the bile acids produced in mammals, such as 7-HOCA. The individual C-25 isomers of ENT-03 were prepared and both detected in mouse brain. Trodusquemine and ENT-03 have both demonstrated dramatic effects in obesity and insulin resistance. (25S)-ENT-03 was selected for development for the treatment of diabetes and obesity.
Small MoleculesSep 19, 2024
How Porton's Expertise Enhances Mutual Benefits in License In/Out Agreements
Porton's extensive expertise in technical transfer, supply chain optimization, and regulatory affairs (RA) knowledge significantly benefits both parties involved in license in and out scenarios.